ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Vanderbilt physician-scientist Philip Browning, 51, dead of colon cancer.

June 25, 2004

NIH Drops Objections To Bill For Research On Environmental Causes of Breast Cancer.

May 23, 2008

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

New Guidelines Developed For Cooperative Group Grant Review

August 17, 1979

In Brief: Morton Leaves UCLA Surgical Oncology; Rall Resigns As NIH Deputy for Intramural Research

May 17, 1991